Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 March 1998

Cardiac electrophysiology of chronic fluoxetine treatment in diabetic rats

Pal Pacher, Zoltan Ungvari, Julia Timar, Susanna Gyarmati, Kornelia Tekes, Valeria Kecskemeti

Med Sci Monit 1998; 4(2): BR202-208 :: ID: 502537

Abstract

Objective: We aimed to investigate the effects of chronic fluoxetine (a selective serotonin reuptake antidepressant inhibitor) treatment (10 mg/kg per os, daily for 6-8 weeks) on action potential (AP) characteristics of isolated right ventricular papillary muscles and left atria of streptozotocin-induced (60 m/kg iv.) diabetic and agematched control rats. Methods: A conventional glass microelectrode technique was used to record AP parameters.
Results: The duration of AP (APD) of diabetic ventricular as well as atrial muscles were significantly increased with no significant differences in the resting membrane potential and maximum rate of the rise of depolarization phase of AP (Vmax or dv/dt). Chronic fluoxetine treatment slightly, but not significantly decreased the action potential amplitude (APA) and Vmax both in control and diabetic groups but did not modify other parameters of APs. Conclusion: The electrophysiological changes found in diabetic heart preparations are mainly due to a decrease in outward K+ current (Ito), with a possible contribution of altered Ca2+ current(s). Some of these electrophysiological alterations may explain certain characteristic pathological ECG changes (T wave flattening or inversion, reentry arrhytmias) encountered frequently in diabetic patients. Fluoxetine seems to be a well tolerated, safe antidepressant in therapeutic doses even in high risk, diabetic patients, although a slight decrease found in APA and Vmax may indicate that this drug administered in higher doses can exert certain cardiodepressive effects.

Keywords: cardiac action potential, diabetes, fluoxetine, Rat

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750